{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:55:29Z","timestamp":1772805329368,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["608765"],"award-info":[{"award-number":["608765"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","award":["IUT20-14 (TLOKT14014I)"],"award-info":[{"award-number":["IUT20-14 (TLOKT14014I)"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PUTJD22"],"award-info":[{"award-number":["PUTJD22"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eesti Teadusfondi, ERA-Net PRIOMEDCHILD program","award":["18\/2011"],"award-info":[{"award-number":["18\/2011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00216-017-0255-4","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T04:03:09Z","timestamp":1487649789000},"page":"3145-3151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Signal Enhancement in the HPLC-ESI-MS\/MS analysis of spironolactone and its metabolites using HFIP and NH4F as eluent additives"],"prefix":"10.1007","volume":"409","author":[{"given":"Kalev","family":"Takkis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Aro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenne-Triin","family":"K\u00f5rgvee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heili","family":"Varendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Lass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koit","family":"Herodes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-8993","authenticated-orcid":false,"given":"Karin","family":"Kipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"255_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s11936-009-0045-1","volume":"11","author":"EM Volz","year":"2009","unstructured":"Volz EM, Felker GM. How to use diuretics in heart failure. Curr Treat Options Cardiovasc Med. 2009;11:426\u201332.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"255_CR2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/ajhp\/61.suppl_2.S14","volume":"61","author":"PE Nolan","year":"2004","unstructured":"Nolan PE. Integrating traditional and emerging treatment options in heart failure. Am J Health-Syst Pharm. 2004;61:S14\u201322.","journal-title":"Am J Health-Syst Pharm"},{"issue":"5","key":"255_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1464-5491.2004.01194.x","volume":"21","author":"R Rachmani","year":"2004","unstructured":"Rachmani R, Slavachevsky I, Amit M, Levi Z, Kedar Y, Berla M, et al. The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabet Med. 2004;21(5):471\u20135.","journal-title":"Diabet Med"},{"issue":"4","key":"255_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","volume":"25","author":"SS Lane DA","year":"2007","unstructured":"DA Lane SS, Beevers DG. Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J Hypertens. 2007;25(4):891\u20134.","journal-title":"J Hypertens"},{"issue":"6","key":"255_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jacc.2009.03.066","volume":"54","author":"NC Edwards","year":"2009","unstructured":"Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease. J Am Coll Cardiol. 2009;54(6):505\u201312.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"255_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/pds.3748","volume":"24","author":"S Abbas","year":"2015","unstructured":"Abbas S, Ihle P, Harder S, Schubert I. Risk of hyperkalemia and combined use of spironolactone and long-term ACE inhibitor\/angiotensin receptor blocker therapy in heart failure using real-life data: a population- and insurance-based cohort. Pharmacoepidemiol Drug Saf. 2015;24(4):406\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"255_CR7","doi-asserted-by":"publisher","first-page":"E138","DOI":"10.1503\/cmaj.140816","volume":"187","author":"T Antoniou","year":"2015","unstructured":"Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, et al. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. CMAJ. 2015;187(4):E138\u201343.","journal-title":"CMAJ"},{"issue":"5","key":"255_CR8","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3109\/10641963.2015.1131290","volume":"38","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang H, Cai M, Zou Y, Jiang X, Song L, et al. Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clin Exp Hypertens. 2016;38(5):464\u20138.","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"255_CR9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/jms.1006","volume":"41","author":"H Dong","year":"2006","unstructured":"Dong H, Xu F, Zhang Z, Tian Y, Chen Y. Simultaneous determination of spironolactone and its active metabolite canrenone in human plasma by HPLC-APCI-MS. J Mass Spectrom. 2006;41(4):477\u201386.","journal-title":"J Mass Spectrom"},{"issue":"1-2","key":"255_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jchromb.2006.02.017","volume":"839","author":"JM Sandall","year":"2006","unstructured":"Sandall JM, Millership JS, Collier PS, McElnay JC. Development and validation of an HPLC method for the determination of spironolactone and its metabolites in paediatric plasma samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2006;839(1-2):36\u201344.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"255_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5562\/cca1761","volume":"84","author":"L Vlase","year":"2011","unstructured":"Vlase L, Imre S, Muntean D, Achim M, Muntean D. Determination of spironolactone and canrenone in human plasma by high-performance liquid chromatography with mass spectrometry detection. Croat Chem Acta. 2011;84(3):361\u20136.","journal-title":"Croat Chem Acta"},{"key":"255_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jchromb.2013.08.010","volume":"937","author":"E Dias","year":"2013","unstructured":"Dias E, Hachey B, McNaughton C, Nian H, Yu C, Straka B, et al. An LC-MS assay for the screening of cardiovascular medications in human samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;937:44\u201353.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"255_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40005-015-0197-9","volume":"45","author":"J-H Lee","year":"2015","unstructured":"Lee J-H, An T-G, Kim SJ, Shim W-S, Lee K-T. Development of liquid chromatography tandem mass spectrometry method for determination of spironolactone in human plasma: application to a bioequivalence study of Daewon Spiracton tablet\u00ae (spironolactone 50 mg). J Pharm Investig. 2015;45(6):601\u20139.","journal-title":"J Pharm Investig"},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"8826","DOI":"10.1021\/ac901341c","volume":"81","author":"W Wang","year":"2009","unstructured":"Wang W, Cole RB. Enhanced collision-induced decomposition efficiency and unraveling of fragmentation pathways for anionic adducts of brevetoxins in negative ion electrospray mass spectrometry. Anal Chem. 2009;81:8826\u201338.","journal-title":"Anal Chem"},{"key":"255_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jchromb.2012.02.034","volume":"893-894","author":"T Fiers","year":"2012","unstructured":"Fiers T, Casetta B, Bernaert B, Vandersypt E, Debock M, Kaufman JM. Development of a highly sensitive method for the quantification of estrone and estradiol in serum by liquid chromatography tandem mass spectrometry without derivatization. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;893-894:57\u201362.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"255_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jchromb.2014.12.005","volume":"978-979","author":"M Witting","year":"2015","unstructured":"Witting M, Rudloff HC, Thondamal M, Aguilaniu H, Schmitt-Kopplin P. Fast separation and quantification of steroid hormones Delta4- and Delta7-dafachronic acid in Caenorhabditis elegans. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;978-979:118\u201321.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"6","key":"255_CR17","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/ac102981k","volume":"83","author":"O Yanes","year":"2011","unstructured":"Yanes O, Tautenhahn R, Patti GJ, Siuzdak G. Expanding coverage of the metabolome for global metabolite profiling. Anal Chem. 2011;83(6):2152\u201361.","journal-title":"Anal Chem"},{"key":"255_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.scitotenv.2014.02.085","volume":"484","author":"E Carmona","year":"2014","unstructured":"Carmona E, Andreu V, Pico Y. Occurrence of acidic pharmaceuticals and personal care products in Turia River Basin: from waste to drinking water. Sci Total Environ. 2014;484:53\u201363.","journal-title":"Sci Total Environ"},{"key":"255_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.chroma.2015.05.010","volume":"1401","author":"JJ Pesek","year":"2015","unstructured":"Pesek JJ, Matyska MT. Ammonium fluoride as a mobile phase additive in aqueous normal phase chromatography. J Chromatogr A. 2015;1401:69\u201374.","journal-title":"J Chromatogr A"},{"key":"255_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jchromb.2015.05.039","volume":"998-999","author":"L Yin","year":"2015","unstructured":"Yin L, Meng X, Zhou X, Zhang T, Sun H, Yang Z, et al. Simultaneous determination of carboprost methylate and its active metabolite carboprost in dog plasma by liquid chromatography-tandem mass spectrometry with positive\/negative ion-switching electrospray ionization and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;998-999:8\u201314.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"255_CR21","unstructured":"Guideline on bioanalytical method validation: European Medicines Agency; 2011. Available from: http:\/\/www.ema.europa.eu ."},{"key":"255_CR22","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1021\/ac020361s","volume":"75","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS. Anal Chem. 2003;75:3019\u201330.","journal-title":"Anal Chem"},{"key":"255_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1248\/bpb.28.1126","volume":"28","author":"T Tokumura","year":"2005","unstructured":"Tokumura T, Muraoka A, Mautomi T, Machida Y. Stability of spironolactone in rat plasma: strict temperature control of blood and plasma samples is required in rat pharmacokinetic studies. Biol Pharm Bull. 2005;28:1126\u20138.","journal-title":"Biol Pharm Bull"},{"key":"255_CR24","unstructured":"Takkis K, Aro R, Kipper K, Varendi H, Herodes K. Signal enhancement in HPLC-ESI-MS\/MS analysis of spironolactone metabolites using HFIP and NH4F as eluent additives. Mass spectrometry: applications to the clinical lab (MSACL 2015). 8th annual conference & exhibits; 28.03.2015-01.04.2015. San Diego; 2015."}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-017-0255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-017-0255-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-017-0255-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T18:36:43Z","timestamp":1568831803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-017-0255-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1007\/s00216-017-0255-4","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}